Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/01/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Employee Stock Option (Right to Buy) | 125.3k | $5.35 | $670.3k | | 03/01/2023 |
03/01/2023 | Poseida Therapeutics, Inc. | PSTX | Payment of Exercise | Common Stock | 4.3k | $5.35 | $23.1k | | 03/01/2023 |
03/01/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Common Stock | 92.8k | $0.00 | $0 | | 03/01/2023 |
12/21/2021 | Poseida Therapeutics, Inc. | PSTX | Exercise | Stock Option (Right to Buy) | 3.1k | $1.93 | $6k | | 12/21/2021 |
12/21/2021 | Poseida Therapeutics, Inc. | PSTX | Exercise | Stock Option (Right to Buy) | 2.6k | $1.17 | $3.1k | | 12/21/2021 |
11/01/2021 | Poseida Therapeutics, Inc. | PSTX | Grant | Employee Stock Option (Right to Buy) | 65k | $6.53 | $424.4k | | 11/01/2021 |
02/04/2021 | Poseida Therapeutics, Inc. | PSTX | Grant | Employee Stock Option (Right to Buy) | 82k | $9.15 | $750.3k | | 02/04/2021 |
01/15/2021 | Poseida Therapeutics, Inc. | PSTX | Exercise | Stock Option (Right to Buy) | 4.2k | $0.30 | $1.3k | | 01/15/2021 |
01/15/2021 | Poseida Therapeutics, Inc. | PSTX | Exercise | Stock Option (Right to Buy) | 551 | $0.30 | $165.3 | | 01/15/2021 |
07/09/2020 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 35k | $16.00 | $560k | | 07/09/2020 |